Such findings might depend on the presence of obesity, arterial hypertension, and diabetes in samples generally chosen for this kind of investigation [73,74,75], as an RCT excluding these comorbidities reported a significant CRP reduction [76,77,78]. This evidence concerns the gene CRP and obesity disorder.